These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20849302)

  • 1. Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal.
    Diop-Ndiaye H; Toure-Kane C; Leye N; Ngom-Gueye NF; Montavon C; Peeters M; Mboup S
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1133-8. PubMed ID: 20849302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir.
    Ananworanich J; Hirschel B; Sirivichayakul S; Ubolyam S; Jupimai T; Prasithsirikul W; Chetchotisakd P; Kiertiburanakul S; Munsakul W; Raksakulkarn P; Tansuphasawadikul S; Schutz M; Snowden W; Ruxrungtham K;
    Antivir Ther; 2006; 11(5):631-5. PubMed ID: 16964832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
    Derache A; Maiga AI; Traore O; Akonde A; Cisse M; Jarrousse B; Koita V; Diarra B; Carcelain G; Barin F; Pizzocolo C; Pizarro L; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic resistance to antiretroviral drugs in patients infected with several HIV type 1 genetic forms in Cuba.
    Pérez L; Alvarez LP; Carmona R; Aragonés C; Delgado E; Thomson MM; González Z; Contreras G; Pérez J; Nájera R
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):407-14. PubMed ID: 17411374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia.
    Tee KK; Kamarulzaman A; Ng KP
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):121-4. PubMed ID: 16478392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
    Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy.
    Bonura F; Tramuto F; Vitale F; Perna AM; Viviano E; Romano N;
    AIDS Res Hum Retroviruses; 2010 Sep; 26(9):961-5. PubMed ID: 20707733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
    Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
    HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.
    Ayouba A; Lien TT; Nouhin J; Vergne L; Aghokeng AF; Ngo-Giang-Huong N; Diop H; Kane CT; Valéa D; Rouet F; Joulia-Ekaza D; Toni TD; Nerrienet E; Ngole EM; Delaporte E; Costagliola D; Peeters M; Chaix ML
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1193-6. PubMed ID: 19886834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of drug resistance mutations among drug-naive patients in Morocco.
    Annaz HE; Recordon-Pinson P; Baba N; Sedrati O; Mrani S; Fleury H
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):917-20. PubMed ID: 21087198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
    Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
    PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
    Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].
    Si XF; Huang HL; Wei M; Guan Q; Song YH; Ma PF; Quan Y; Xing H; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):308-11. PubMed ID: 15650776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality.
    Eyer-Silva WA; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Dec; 100(8):869-73. PubMed ID: 16444418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
    Soriano V
    Antivir Ther; 1999; 4 Suppl 3():57-63. PubMed ID: 16021872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.